Lactobacillus helveticus strain and composition containing same for prevention or treatment of inflammatory diseases
AssigneesGi Biome, Mediogen Co., Ltd.
InventorsBo Gie Yang, Myung Ho Jang, Chang Ho Kang, Nam Soo Paek
Life of this patent
Estimating the term…
Abstract
Provided are a Lactobacillus helveticus strain and a composition for preventing or treating inflammatory disease containing the same. The Lactobacillus helveticus strain (Accession No. KCTC 14110BP) according to the present invention alleviates symptoms of inflammatory bowel disease, such as weight loss and bowel length reduction, and it does not have side effects that have been seen with existing drug treatment. Therefore, the Lactobacillus helveticus strain can be effectively used for the treatment and prevention of inflammatory disease, particularly inflammatory bowel disease.
Claims9
A pharmaceutical composition comprising, as an active ingredient, lactic acid bacteria consisting of a Lactobacillus helveticus strain deposited as Accession No. KCTC 14110BP or a culture thereof, wherein the pharmaceutical composition is formulated into an oral formulation, wherein the formulation for oral administration is tablets, pills, capsules, gels, syrups or suspensions.
A method for treating inflammatory disease comprising:
- administering a Lactobacillus helveticus strain deposited as Accession No. KCTC 14110BP or a culture thereof to a subject.
Dependencies are inferred from the claim text.